Investing
Top Day Trader Alerts (ACTL, BBI, BP, CTIC, CRNT, ONXX, ROSE, THQI)
Published:
Last Updated:
There are several big movers this morning for day traders and active traders that look for stocks with gap-ups or gap-downs. Stocks with news or events causing moves are Actel Corporation (NASDAQ: ACTL), Blockbuster Inc. (NYSE: BBI), BP plc (NYSE: BP), Cell Therapeutics, Inc. (NASDAQ: CTIC), Ceragon Networks Ltd. (NASDAQ: CRNT), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX), Rosetta Resources, Inc. (NASDAQ: ROSE), and THQ Inc. (NASDAQ: THQI). We have provided the color on each and the move on each with background data where applicable.
Actel Corporation (NASDAQ: ACTL) is down after it announced that Q2 revenues are expected to come in at the low end of the previous guidance of +8% to +12% sequentially. Shares are trading down 3.5% at $13.61 on very thin trading volume, and its 52-week range is $10.03 to $17.10. Average daily volume is only 71K shares.
Blockbuster Inc. (NYSE: BBI) is just about dead if the news is accurate. It is still reportedly considering bankruptcy. As the stock has already compressed so much, Blockbuster shares are down 5% at $0.26 and the 52-week range is $0.24 to $1.56. Hardly a blockbuster.
BP plc (NYSE: BP) is becoming a permanent member of top day trader alerts, probably because they are in the soup over and over. Shares are lower on talk of a dividend cut, talk of $10 billion or more being demanded to be put in escrow, and the notion that BP said it has some 51,000 claims amounting to $1.6 billion so far.
Cell Therapeutics, Inc. (NASDAQ: CTIC) is one of the top gainers this morning on a press release that the Italian Medicines Agency approved NerPharMa to manufacture Cell Therapeutics’ drug Pixantrone in the European Union. This was also an UNUSUAL SUSPECT stock over the weekend as we noted “this has a chance for a trader-interest revival after the penny stock imploded earlier this year” due to new news. Shares are trading up 18% at $0.53 on well over 500K shares, although the stock was up over 20% a few minutes before.
Ceragon Networks Ltd. (NASDAQ: CRNT) is up after getting a $9 million follow-on order from teh Philippines for a 2G/3G backhaul expansion. While the gain is on thin volume, the shares are up 7.3% at $7.78 versus a 52-week range of $6.14 to $13.29.
Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) is trading lower after it and Bayer’s Nexavar, a potential lung cancer treatment, failed to meet some endpoints in a Phase III trial. Shares are down 5% at $21.66, which will be a new 52-week low if it holds as the prior range was $21.77 to $36.75.
Rosetta Resources, Inc. (NASDAQ: ROSE) is trading up, albeit a bit smaller than expected in pre-market trading after being featured in our UNUSUAL SUSPECTS. Barron’s called it a BUY with shares possibly doubling. Monday’s pre-market trading has shares up 3% at $26.00 on close to 20,000 shares.
THQ Inc. (NASDAQ: THQI) is getting clipped after lowering guidance for Q1: it now sees an adjusted loss of -$0.20 to -$0.30 EPS versus a previous outlook of a breakeven with sales of $155 to $165 million versus its prior forecast of $190 to $200 million. The video game publisher’s shares are down 7.2% at $5.15 on fairly thin volume, and its 52-week range is $4.12 to $8.82.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Sponsor: 3 Recovery Stocks to Own Now – Get the names of the best cheap stocks to rebuild your wealth in 2010 and beyond.
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.